Elusys Therapeutics concludes study on anthrax antitoxin

Tuesday, Sep 23, 2014 @ 1:24pm by BioPrepWatch Reports

Elusys Therapeutics announced on Monday that it has completed a three-phase study on an antitoxin in development to treat anthrax.
Read More »

Kentucky appoints assistant director of emergency management

Tuesday, Sep 23, 2014 @ 1:25pm by BioPrepWatch Reports

Kentucky Emergency Management (KYEM) recently appointed Richard "Rich" Knighten as its assistant director of operations.
Read More »

NUSTL seeks information for program to aid emergency responders

Wednesday, Sep 24, 2014 @ 7:15am by BioPrepWatch Reports

The National Urban Security Technology Laboratory (NUSTL) issued a call on Monday for information on available CBRN SCBA for a new program for emergency responders.
Read More »

21st Century Cures initiative discusses growing threat of antibiotic resistance

Wednesday, Sep 24, 2014 @ 7:21am by BioPrepWatch Reports

Politicians and health experts gathered for the Subcommittee on Health on Sept. 19 to discuss the future of drug resistance and explore options to decrease this threat under the committee's 21st Century Cures initiative.
Read More »

FDA issues Food Safety Challenge

Wednesday, Sep 24, 2014 @ 7:25am by BioPrepWatch Reports

The Food and Drug Administration (FDA) has issued the Food Safety Challenge in order to discover groundbreaking methods for detecting disease-causing agents in food.
Read More »

NAEMT discusses patient care progress with congressmen

Wednesday, Sep 24, 2014 @ 7:45am by BioPrepWatch Reports

The National Association of Emergency Medical Technicians (NAEMT) gathered on Sept. 18 to discuss the transformations taking place with emergency patient care in the field.
Read More »

Soligenix appoints new VP of biopharmaceutical development

Wednesday, Sep 24, 2014 @ 12:27pm by BioPrepWatch Reports

Soligenix Inc., a biopharmaceutical company developing products in the areas of inflammation, oncology and biodefense, named Rasappa Arumugham vice president of Biopharmaceutical Development on Tuesday.
Read More »

PositiveID to develop rapid molecular testing prototype

Wednesday, Sep 24, 2014 @ 12:29pm by BioPrepWatch Reports

PositiveID Corporation will focus attention and resources on developing the Firefly Dx system, which promises to provide rapid results of molecular testing, according to a company announcement on Tuesday.
Read More »

CDC Director Frieden: Treatment delays could lead to 1.4 million ebola cases by January

Wednesday, Sep 24, 2014 @ 12:38pm by BioPrepWatch Reports

The U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday that 1.4 million people in Liberia and Sierra Leone could potentially be infected with the Ebola virus by the end of January, but then tempered that estimate by saying increased global awareness and medical care could stem the spread of the virus.
Read More »

Michigan healthcare personnel train for response, recovery

Thursday, Sep 25, 2014 @ 1:40am by BioPrepWatch Reports

Roughly 140 healthcare personnel from across Michigan attended training at the Center for Domestic Preparedness' (CDP) Noble Training Facility (NTF) recently.
Read More »

Leidos receives GovConnects Government Contractor of the Year award

Thursday, Sep 25, 2014 @ 1:46am by BioPrepWatch Reports

Leidos, a company specializing in national security, health and engineering solutions, recently received the GovConnects Government Contractor of the Year award from the Harris County Chamber of Commerce.
Read More »

FEMA announces youth disaster preparedness program

Thursday, Sep 25, 2014 @ 1:51am by BioPrepWatch Reports

FEMA announced youth disaster preparedness program The Federal Emergency Management Agency (FEMA) announced today a program to increase readiness by youth for disaster preparedness.
Read More »

NACCHO provides update on smallpox preparedness planning

Friday, Sep 26, 2014 @ 7:23am by BioPrepWatch Reports

In a congressional exercise, policymakers took the opportunity to assess the decisions that would have to be made in the event of an Anthrax or Smallpox attack on Sept. 8.
Read More »

Elizabeth Zimmerman, Robert Fenton appointed to FEMA Office of Response and Recovery

Friday, Sep 26, 2014 @ 7:28am by BioPrepWatch Reports

The Federal Emergency Management Agency (FEMA) Cheif of Staff, Michael Coen, Jr. named Elizabeth Zimmerman as the acting associate administrator and Robert Fenton as the deputy associate administrator of the Office of Response and Recovery.
Read More »

TapImmune completes pre-clinical smallpox program at Mayo Clinic

Friday, Sep 26, 2014 @ 7:37am by BioPrepWatch Reports

TapImmune CEO Glynn Wilson recently announced completion of the company’s pre-clinical Smallpox program at the Mayo Clinic in Rochester, Minn., and updated shareholders on progress in the company’s other clinical programs. With the end of the pre-clinical Smallpox program, researchers are now planning for research in non-human primates.
Read More »

Global Counterterrorism Forum details counterterrorism efforts

Friday, Sep 26, 2014 @ 7:47am by BioPrepWatch Reports

The Global Counterterrorism Forum (GCTF) released a fact sheet on Sept. 23 that detailed efforts of member countries to develop action plans to meet civilian counterterrorism goals and actions that specific countries were taking to further the forum’s goals.
Read More »

HHS agrees to fund WHO initiative

Friday, Sep 26, 2014 @ 2:01pm by BioPrepWatch Reports

The U.S. Department of Health and Human Services (HHS) agreed on Wednesday to fund an initiative that could create a regulatory pathway allowing the World Health Organization (WHO) to deploy medical countermeasures internationally in the event of an emergency.
Read More »

Emergency preparedness council discusses disabled services

Friday, Sep 26, 2014 @ 2:01pm by BioPrepWatch Reports

Representatives for the Interagency Coordinating Council (ICC) on Emergency Preparedness and Individuals with Disabilities met on Sept. 11 to solidify plans for the Fiscal Year 2015 exercise initiative, which includes coordination of programs and services that impact disabled disaster survivors.
Read More »

Vaccine for Ebola to move into human trial

Monday, Sep 29, 2014 @ 6:05am by BioPrepWatch Reports

Inovio Pharmaceuticals, Inc. announced that its vaccine, SynCon, against the Ebola virus will enter the first phase of clinical trials this past Tuesday.
Read More »

The Scripps Research Institute receives funding to develop artificial immune system

Monday, Sep 29, 2014 @ 6:14am by BioPrepWatch Reports

The U.S.
Read More »